| Financial Year |
March 31 2023 |
| Monetary Funds |
1,004,937,671.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
78,892,475.54 |
| Accounts Receivable |
393,186,806.68 |
| Advances to Suppliers |
145,054,615.89 |
| Other Receivables |
67,218,659.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
385,839,355.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,408,748.15 |
| Total Current Assets |
2,135,133,639.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
54,490,137.49 |
| Long-term Equity Investment |
149,009,708.88 |
| Investment Properties |
19,110,596.72 |
| Fixed Assetes |
147,351,289.96 |
| Under-construction Projects |
112,759,594.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,673,836.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,971,797.89 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
533,931,053.39 |
| Total Assets |
2,669,064,692.67 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
248,602,470.99 |
| Accounts Payable |
322,269,947.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,823,247.08 |
| Taxes Payable |
2,135,655.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,673,089.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
223,592.30 |
| Other Current Liabilities |
17,501,150.58 |
| Sub-Total of Current Liabilities |
762,283,878.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,461,738.00 |
| Total Liabilities |
772,745,616.71 |
| Paid-In Capital(Or Share Stock) |
518,980,440.00 |
| Capital Surplus |
692,837,929.93 |
| Surplus Reserve |
121,713,864.44 |
| LESS:Treasury Stock |
21,155,494.80 |
| Undistributed Profits |
583,942,336.39 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,896,319,075.96 |
| Owner's Equity（Stockholder's Equity） |
1,896,319,075.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,669,064,692.67 |
